Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days
- PMID: 32291828
- PMCID: PMC7235523
- DOI: 10.1111/dth.13415
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22. Dermatol Ther. 2020. PMID: 32157783 Free PMC article. No abstract available.
References
-
- Kalb RE et al. Risk of serious infection with biologic and systemic treatment of psoriasis: results from the psoriasis longitudinal assessment and registry (PSOLAR). JAMA Dermatol. 2015. Sep;151(9):961‐969. - PubMed
-
- Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford). 2013. Jan;52(1):53‐61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
